GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bioxyne Ltd (ASX:BXN) » Definitions » EV-to-FCF

Bioxyne (ASX:BXN) EV-to-FCF : -3.65 (As of May. 21, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Bioxyne EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Bioxyne's Enterprise Value is A$10.75 Mil. Bioxyne's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was A$-2.95 Mil. Therefore, Bioxyne's EV-to-FCF for today is -3.65.

The historical rank and industry rank for Bioxyne's EV-to-FCF or its related term are showing as below:

ASX:BXN' s EV-to-FCF Range Over the Past 10 Years
Min: -57.16   Med: -2.09   Max: 1010.92
Current: -3.65

During the past 13 years, the highest EV-to-FCF of Bioxyne was 1010.92. The lowest was -57.16. And the median was -2.09.

ASX:BXN's EV-to-FCF is ranked worse than
100% of 1166 companies
in the Consumer Packaged Goods industry
Industry Median: 17.715 vs ASX:BXN: -3.65

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-21), Bioxyne's stock price is A$0.006. Bioxyne's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.008. Therefore, Bioxyne's PE Ratio for today is At Loss.


Bioxyne EV-to-FCF Historical Data

The historical data trend for Bioxyne's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioxyne EV-to-FCF Chart

Bioxyne Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.63 264.08 308.96 12.98 -28.62

Bioxyne Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 12.98 - -28.62 -

Competitive Comparison of Bioxyne's EV-to-FCF

For the Packaged Foods subindustry, Bioxyne's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioxyne's EV-to-FCF Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Bioxyne's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Bioxyne's EV-to-FCF falls into.



Bioxyne EV-to-FCF Calculation

Bioxyne's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=10.754/-2.945
=-3.65

Bioxyne's current Enterprise Value is A$10.75 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bioxyne's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was A$-2.95 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioxyne  (ASX:BXN) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bioxyne's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.006/-0.008
=At Loss

Bioxyne's share price for today is A$0.006.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bioxyne's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.008.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Bioxyne EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Bioxyne's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioxyne (ASX:BXN) Business Description

Traded in Other Exchanges
N/A
Address
50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000
Bioxyne Ltd is an Australian life science and health products company. The company is engaged in the development, manufacture, and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus Fermentum PCC. Some of its products include Breathe life Science, Dr Watson, BLS Clinics, Mirai Solution, CanXChange etc. It operates in three segments: wholesale sales, Plant based and direct sales. The majority of the revenue is generated from Plant based in the United Kingdom, Europe and Japan.

Bioxyne (ASX:BXN) Headlines

No Headlines